Abstract: Disclosed are a stabilizer for storage of a biological sample, a composition for storage of a nucleic acid and/or a polypeptide in a biological sample under non-freezing conditions, a kit comprising the composition, a mixture comprising the composition and a biological sample, and a method for storage of a nucleic acid and/or a polypeptide in a biological sample under non-freezing conditions. The integrity and stability of the nucleic acid and/or polypeptide in a biological sample can be stored for a long time under non-freezing conditions by using the stabilizer according to the invention, and therefore the stabilizer has a good application prospect.

Abstract: Methods for production of platelets from pluripotent stem cells, such as human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs) are provided. These methods may be performed without forming embryoid bodies or clusters of pluripotent stem cells, and may be performed without the use of stromal inducer cells. Additionally, the yield and/or purity can be greater than has been reported for prior methods of producing platelets from pluripotent stem cells. Also provided are compositions and pharmaceutical preparations comprising platelets, preferably produced from pluripotent stem cells.

Abstract: Biomarkers for diabetes and usages thereof are provided. And the biomarkers are nucleotides having polynucleotide sequences defined in SEQ ID NOs: 1-50.

Abstract: Methods for production of platelets from pluripotent stem cells, such as human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs) are provided. These methods may be performed without forming embryoid bodies or clusters of pluripotent stem cells, and may be performed without the use of stromal inducer cells. Additionally, the yield and/or purity can be greater than has been reported for prior methods of producing platelets from pluripotent stem cells. Also provided are compositions and pharmaceutical preparations comprising platelets, preferably produced from pluripotent stem cells.

Abstract: A data packet forwarding method and a network device, where the method includes, receiving a data packet, obtaining a local physical address and a destination physical address of the data packet when the entry matching the data packet does not exist in the first match table, determining whether the local physical address is the same as the destination physical address, searching a second match table for an entry in which a physical address matches the destination physical address when the local physical address is different from the destination physical address, generating a layer 2 forwarding entry according to the entry matching the destination physical address, and forwarding the data packet according to the layer 2 forwarding entry. Therefore, processing efficiency of the new data packet and network performance are improved.

Abstract: Provided is staphylococcus protein A expressed by a mutational Staphylococcus aureus and its coding sequence, as well as a vector, host bacteria, composition or kit which contains the coding sequence of the mutational protein. Also provided is the use of the mutational protein and the composition thereof in the preparation of vaccines, therapeutic antibodies, diagnostic kits and the like, and for the prevention, treatment and detection of infections by Staphylococcus aureus. Also provided are methods for producing, fermenting and purifying the mutational protein.

Abstract: The present disclosure discloses a flow table matching method and apparatus and an OpenFlow switching system to implement matching of any field in any data flow without changing existing hardware logic or a standard protocol. The method includes: receiving a jump instruction and a match instruction that are delivered by a controller for a first flow table; creating a first flow entry in the first flow table; receiving a flow mode message delivered by the controller for a second flow table; and creating a second flow entry in the second flow table. The present disclosure lays a foundation for implementing really flexible and programmable software-defined networking, assists a network service operator in reducing capital expenditures and operation expenditures, and enables a traditional IP network to have more flexible network abstraction and management capabilities for a real-time service.

Abstract: Methods for production of platelets from pluripotent stem cells, such as human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs) are provided. These methods may be performed without forming embryoid bodies or clusters of pluripotent stem cells, and may be performed without the use of stromal inducer cells. Additionally, the yield and/or purity can be greater than has been reported for prior methods of producing platelets from pluripotent stem cells. Also provided are compositions and pharmaceutical preparations comprising platelets, preferably produced from pluripotent stem cells.

Abstract: A data transmission method in software-defined networking (SDN) environment using transmission control protocol (TCP). An application server sends a transmission resource allocation request to a controller. The request carries an address of a sending device and an address of a receiving device. The controller determines a first transmission path and a second transmission path between the sending device and the receiving device according to the request. The first transmission path is used by the sending device to transmit data to the receiving device, and the second transmission path is used by the receiving device to transmit an acknowledgment to the sending device. The controller sends a transmission resource allocation response to the application server. The application server determines, according to the response, an initial value of a transmit window for transmitting data. The sending device transmits the data to the receiving device according to the transmit window.

Abstract: Methods for production of platelets from pluripotent stem cells, such as human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs) are provided. These methods may be performed without forming embryoid bodies or clusters of pluripotent stem cells, and may be performed without the use of stromal inducer cells. Additionally, the yield and/or purity can be greater than has been reported for prior methods of producing platelets from pluripotent stem cells. Also provided are compositions and pharmaceutical preparations comprising platelets, preferably produced from pluripotent stem cells.

Abstract: The present invention relates to a disease-specific metabolite profile, and particularly to a biomarker composition obtained by screening from urine-specific metabolite profiles of coronary heart disease subjects. The present invention also relates to a use of the biomarker compositions in risk assessment, diagnosis, early diagnosis, or pathological staging of coronary heart disease, and to a method for risk assessment, diagnosis, early diagnosis, or pathological staging of coronary heart disease. The biomarker composition as provided by the present invention can be used for early diagnosis of coronary heart disease and has high sensitivity, good specificity and good application prospects.

Abstract: Biomarkers and methods for predicting risk of a disease in particular RA are provided. Sequences of DNA are obtained. The DNA may be extracted from a sample that is collected from a subject. A relative abundance of a biomarker is then calculated based on the sequences of the DNA. The biomarker comprises a DNA sequence in a genome of Lactobacillus salivarius. A probability of the subject having the disease is obtained based on the relative abundance.

Abstract: The present invention relates to a disease-specific metabolite profile, and particularly to a biomarker composition obtained by screening from blood plasma-specific profiles of coronary heart disease subjects. The present invention also relates to a use of the biomarker compositions in risk assessment, diagnosis, early diagnosis, or pathological staging of coronary heart disease, and to a method for risk assessment, diagnosis, early diagnosis, or pathological staging of coronary heart disease. The biomarker composition as provided by the present invention can be used for early diagnosis of coronary heart disease and has high sensitivity, good specificity and good application prospects.

Abstract: A method for guaranteeing control traffic throughput in an in-band network configured for delivering control and data traffic, and considering both local and global views of the communication network. The method includes determining an initial configuration for forwarding first control traffic from the packet forwarding device, wherein the initial configuration comprises a first in-band queue for receiving the first control traffic that is delivered over the control path to the controller via a port in the packet forwarding device, and a first bandwidth reserved for the first queue. The method includes performing handshaking with the controller by sending a request to the controller confirming the initial configuration using a network control protocol, and receiving a response from the controller in association with the request. The method includes confirming or modifying the initial configuration based on the response.

Abstract: A data packet processing method, Where the method includes matching a received data packet in a flow table, and determining the received data packet as a newly-established data packet, where the newly-established data packet is a data packet that needs to be reported to a controller to determine a processing manner, determining a target priority of the newly-established data packet, and reporting the newly-established data packet to the controller according to the target priority. Priorities of data packets entering an OPENFLOW switch are determined, and for unsuccessfully matched data packets, a data packet having a high priority is forwarded preferentially according to the priorities, thereby ensuring that data having a high priority is not discarded.

Abstract: A flow entry management method comprises receiving a management instruction for any flow entry, where the management instruction is initiated by a controller connected to a switch, wherein the switch may first determine, according to an obtained management authority level of the the controller relative to the switch and a security level of the any flow entry, when the management authority level of the any controller relative to the the switch is not lower than the security level of the a flow entry corresponding to the management instruction initiated by the any controller, that the controller has an authority to perform corresponding management on the any flow entry, and perform corresponding management on the any flow entry according to the management instruction initiated by the controller.

Abstract: Provided is staphylococcus protein A expressed by a mutational Staphylococcus aureus and its coding sequence, as well as a vector, host bacteria, composition or kit which contains the coding sequence of the mutational protein. Also provided is the use of the mutational protein and the composition thereof in the preparation of vaccines, therapeutic antibodies, diagnostic kits and the like, and for the prevention, treatment and detection of infections by Staphylococcus aureus. Also provided are methods for producing, fermenting and purifying the mutational protein.

Abstract: The present disclosure discloses a flow table matching method and apparatus and an OpenFlow switching system to implement matching of any field in any data flow without changing existing hardware logic or a standard protocol. The method includes: receiving a jump instruction and a match instruction that are delivered by a controller for a first flow table; creating a first flow entry in the first flow table; receiving a flow mode message delivered by the controller for a second flow table; and creating a second flow entry in the second flow table. The present disclosure lays a foundation for implementing really flexible and programmable software-defined networking, assists a network service operator in reducing capital expenditures and operation expenditures, and enables a traditional IP network to have more flexible network abstraction and management capabilities for a real-time service.

Abstract: A method for guaranteeing control traffic throughput in an in-band network configured for delivering control and data traffic, and considering both local and global views of the communication network. The method includes determining an initial configuration for forwarding first control traffic from the packet forwarding device, wherein the initial configuration comprises a first in-band queue for receiving the first control traffic that is delivered over the control path to the controller via a port in the packet forwarding device, and a first bandwidth reserved for the first queue. The method includes performing handshaking with the controller by sending a request to the controller confirming the initial configuration using a network control protocol, and receiving a response from the controller in association with the request. The method includes confirming or modifying the initial configuration based on the response.

Abstract: A multi-level sliding sleeve including an outer cylinder, an inner sliding sleeve, a combined ball socket, a guider, an expander, an upper gland, a lower gland, and a ball. The outer cylinder includes internal threads in an upper end and external threads in a lower end, and the outer cylinder including an external wall including a plurality of drainage holes along the peripheral direction. The inner sliding sleeve is mounted to an inner wall of the outer cylinder through shear pins. The inner sliding sleeve includes a plurality of square holes in the middle along the peripheral direction, each of which is equipped with a ball socket inside. The ball sockets combine together to form a combined ball socket. The combined ball socket is equipped with the guider in the upper end and the expander in the lower end.